Knowledge Center
Patent / Jan 01, 1973
Catalytic dehalogenation, alone or with simultaneous reduction, of 11a-halo-6-deoxy-6-demethyl, 6-methylenetetracyclines by hydrazine
Source:
GB 1360006
Methacycline and .alpha.- and .beta.-doxycycline sulfosalicylates were prepd. by dehalogenating 11a-chloro-6-deoxy-6-demethyl-6-methylene-5-hydroxytetracycline hydrofluoride or p-toluenesulfonate with N2H4.H2O-Pd-C and treating with 5-sulfosalicylic acid.
Also in the Knowledge Center
/ Dec 01, 2015
The importance of human factors in inhaler development: The making of PowdAir®
Read more
Scientific Article
/ Nov 26, 2015
FDA Draft Guidance for Industry: Request for Quality Metrics – FDA-2015-D-2537
Read more
Scientific Article
Scientific Article